Paris-based Lucis, a preventive-health platform that pairs blood biomarker testing with an AI-driven companion app, has raised a $20m Series A led by Singular, with participation from General Catalyst, Y Combinator and angel investors including Céline Lazorthes of Resilience, Manu Lecomte, and backe
⚡
Key Insights
10 editorial insights.
AiFeed24 Team·⏱ 1 min read·Technology
Deep Analysis
Multi-Source Intelligence
Found this useful? Share it!
Related Stories

💻Technology
Engadget Podcast: Diving into the Fitbit Air and the Pope's AI criticism
about 1 hour ago

💻Technology
Japan's Megabanks Get AI-Powered Shield with Latest Cyber Defence Upgrade
about 1 hour ago

💻Technology
These researchers would be in Africa fighting ebola—but Trump cut their funding
about 3 hours ago

💻Technology
Uber to provide shuttle services from select US FIFA World Cup venues
about 2 hours ago
